Neoehrlichiose er en ny flåtoverført infektion

Translated title of the contribution: Neoehrlichiosis is a new tick-borne infection

Rosa Maja Møhring Gynthersen, Fredrikke Christie Knudtzen, Anders Porskrog, Karen A Krogfelt, Mette Frimodt Hansen, Daniel El Fassi, Anne-Mette LEbech, Helene Mens*

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review


Neoeherlichiosis is an emerging tick-borne infection causing disease in individuals with inadequate B-cell responses because of haematologic cancer or treatment with B-cell depletion therapies such as rituximab. The infection has recently been found as a cause of prolonged fever among several patients receiving rituximab in Denmark. This review covers current knowledge on the clinical spectrum among healthy as well as immune compromised individuals, transmission, pathogenesis, diagnosis, and treatment.
Translated title of the contributionNeoehrlichiosis is a new tick-borne infection
Original languageDanish
Article numberV09220554
JournalUgeskrift for Læger
Issue number12
Pages (from-to)1141-1145
Publication statusPublished - 12. Jun 2023


Dive into the research topics of 'Neoehrlichiosis is a new tick-borne infection'. Together they form a unique fingerprint.

Cite this